[HTML][HTML] Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren, RE Chen… - Nature …, 2022 - nature.com
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren… - Nature …, 2022 - econpapers.repec.org
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren… - Nature …, 2022 - ui.adsabs.harvard.edu
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …

[HTML][HTML] Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren, RE Chen, J Wei… - 2021 - europepmc.org
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …

[PDF][PDF] Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies 2 that maintain potency against B. 1.617 3

L Peng, Y Hu, MC Mankowski, P Ren, RE Chen, J Wei… - scienceopen.com
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain
potency against B.1.617 Page 1 SARS-CoV-2 mAbs and CryoEM structures 1 1 Monospecific …

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren… - Nature …, 2022 - profiles.wustl.edu
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …

[PDF][PDF] Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren, RE Chen, J Wei… - researchgate.net
Results Single-cell BCR sequencing of RBD-immunized mice identified enriched BCRs
encoding strong mAbs against SARS-CoV-2. To generate potent and specific mAbs against …

[HTML][HTML] Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren… - Nature …, 2022 - ncbi.nlm.nih.gov
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617

L Peng, Y Hu, MC Mankowski, P Ren… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused over 5
million deaths to date. Although multiple vaccines are available, breakthrough infections …

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B. 1.617.

L Peng, Y Hu, MC Mankowski, P Ren… - Nature …, 2022 - search.ebscohost.com
Abstract COVID-19 pathogen SARS-CoV-2 has infected hundreds of millions and caused
over 5 million deaths to date. Although multiple vaccines are available, breakthrough …